Chief Scientific OFFICER
Jonathan D. Licht, M.D.
Director of the University of Florida Health Cancer Center
The Marshall E. Rinker, Sr. Foundation and David B. and Leighan R. Rinker Chair
Prior to joining the University of Florida Health Cancer Center as director, Dr. Licht was the Johanna Dobe Professor of Medicine and Chief of the Division of Hematology/Oncology at the Northwestern University Feinberg School of Medicine. Licht's laboratory studies aberrant gene regulation repression as a cause of hematologic malignancy, including acute promyelocytic leukemia, multiple myeloma and myeloproliferative neoplasms, and developing small molecules and peptides strategies to revert abnormal gene regulation and treat disease.
Licht has held a Leukemia Society Scholar award and Buroughs Wellcome Clinical Scientist Award in Translational Research. He is currently the Principal Investigator of a Leukemia and Lymphoma Society Specialized Center of Research Excellence grant, studying epigenetic mechanisms in hematological malignancy. He is a Senior Editor of Clinical Cancer Research and serves on the editorial board of Oncogene, Cancer Biology and Therapy and Clinical Epigenetics.
Licht was a Counselor of the American Society for Clinical Investigation and is a member of the Association of American Physicians. He currently serves on the National Cancer Institute Board of Scientific Counselors.